<DOC>
	<DOCNO>NCT01993277</DOCNO>
	<brief_summary>The study open-label comparative effectiveness clinical trial evaluate impact three neuromodulation treatment device improve mental health sobriety status recover substance abuse patient . We intend enroll 200 patient give u sufficient number subject plan comparison . Following informed consent baseline assessment , patient randomly assign receive either 1 ) 15 40-minute session Nexalin Brain Stimulator , cranial electrical stimulation ( CES ) device , once-per-day within 3-week time-frame ; 2 ) 30 20-minute session Fischer Wallace Stimulator , another CES device , twice-per-day within 3-week time-frame ; 3 ) 15 40-minute session DAVID Delight , audio-visual stimulation device ( AVS ) , once-per-day within 3-week time-frame ; OR 4 ) control-group condition 15 40-minute relaxation therapy session once-per-day within 3-week time-frame . All subject reassess end 3 week treatment 1 , 3 , 6 month later . In addition assign treatment , patient also receive standard array service provide Behavioral Health Palm Beaches ( BHOPB ) include clinically appropriate , psychiatric medication management Eye Movement Desensitization Response ( EMDR ) therapy . Patients diagnose Post Traumatic Stress Disorder ( PTSD ) assess determine suitability EMDR suitable , receive 2 EMDR session . Patients without PTSD receive EMDR therapy .</brief_summary>
	<brief_title>Evaluating Neuromodulation Technologies Early Recovery</brief_title>
	<detailed_description />
	<criteria>Adults age 18 75 early recovery substance abuse disorder . The exclusion criterion patient diagnose 1 ) uncontrolled seizure disorder , 2 ) psychotic disorder currently active feature ( e.g. , paranoia ) , 3 ) dissociative identity disorder , 4 ) manic episode within past month , 5 ) patient pacemaker implant vagal nerve stimulator , patient prescribe Subocone , Subutext , &amp; /or psychostimulant medication ( e.g. , Alderol , Concerta , Focalin , Metadate , Vyvance , etc . ) since medication interfere ability neuromodulation device ' ability intend effect patient , 7 ) pregnant woman .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>